Transmembrane Domain Interactions and Residue Proline 378 Are Essential for Proper Structure, Especially Disulfide Bond Formation, in the Human Vitamin K-Dependent γ-Glutamyl Carboxylase † by Tie, Jian-Ke et al.
Transmembrane Domain Interactions and Residue Proline 378 Are
Essential for Proper Structure, Especially Disulfide Bond
Formation, in the Human Vitamin K-Dependent γ-Glutamyl
Carboxylase†
Jian-Ke Tie*,‡, Mei-Yan Zheng‡, Kuang-Ling N. Hsiao‡, Lalith Perera§, Darrel W. Stafford‡,
and David L. Straight‡
Department of Biology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
27599, and National Institute of Environmental Health Sciences, National Institutes of Health,
Research Triangle Park, North Carolina 27709
Abstract
We used recombinant techniques to create a two-chain form (residues 1–345 and residues 346–758)
of the vitamin K-dependent γ-glutamyl carboxylase, a glycoprotein located in the endoplasmic
reticulum containing five transmembrane domains. The two-chain carboxylase had carboxylase and
epoxidase activities similar to those of one-chain carboxylase. In addition, it had normal affinity for
the propeptide of factor IX. We employed this molecule to investigate formation of the one disulfide
bond in carboxylase, the transmembrane structure of carboxylase, and the potential interactions
among the carboxylase’s transmembrane domains. Our results indicate that the two peptides of the
two-chain carboxylase are joined by a disulfide bond. Proline 378 is important for the structure
necessary for disulfide formation. Results with the P378L carboxylase indicate that noncovalent
bonds maintain the two-chain structure even when the disulfide bond is disrupted. As we had
previously proposed, the fifth transmembrane domain of carboxylase is the last and only
transmembrane domain in the C-terminal peptide of the two-chain carboxylase. We show that the
noncovalent association between the two chains of carboxylase involves an interaction between the
fifth transmembrane domain and the second transmembrane domain. Results of a homology model
of transmembrane domains 2 and 5 suggest that not only do these two domains associate but that
transmembrane domain 2 may interact with another transmembrane domain. This latter interaction
may be mediated at least in part by a motif of glycine residues in the second transmembrane domain.
The vitamin K-dependent γ-glutamyl carboxylase is a 758-residue integral membrane
glycoprotein of the endoplasmic reticulum (ER).1 It catalyzes the posttranslational
modification of specific glutamic acid residues of vitamin K-dependent proteins to γ-
carboxyglutamic acid residues. This posttranslational modification is critical for the biological
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functions of the vitamin K-dependent proteins involved in blood coagulation, bone metabolism,
signal transduction, and cell proliferation (1–3). Concomitant with carboxylation vitamin K
hydroquinone is oxidized to vitamin K epoxide (epoxidation). The epoxide must be converted
back to the hydroquinone by the enzyme vitamin K epoxide reductase, thus completing the
vitamin K cycle (3).
A number of residues in the carboxylase have been implicated in function. The propeptide of
vitamin K-dependent proteins appears to be the primary substrate recognition sequence for
carboxylase (4). Tight binding at the site supports a processive mechanism in which multiple
carboxylations occur during a single binding event (5). On the basis of affinity peptide–
substrate labeling, Yamada et al. reported that the propeptide binds to the carboxylase between
residues 50 and 225 (6). Propeptide cross-linking experiments from our laboratory suggested
that the propeptide binding region of carboxylase is between residues 438 and 507 (7). Further
studies employing site-directed mutagenesis showed that at least part of the propeptide binding
region includes residues between 495 and 513 of the carboxylase (8).
Kuliopulos et al. suggested that the glutamate residue binding site is located within the first
218 amino acid residues (9). Mutucumarana et al. identified several residues in the region of
a naturally occurring carboxylase mutation (L394R) that also appear to be involved in
glutamate substrate binding (10). Recently, Rishavy et al. presented evidence that lysine,
specifically K218, may be the essential base that deprotonates vitamin K hydroquinone to
initiate the carboxylation reaction (11).
At present, the only structural model for the carboxylase is the membrane topology (12).
According to this model the carboxylase spans the membrane five times with its amino terminus
located in the cytoplasm and the large hydrophilic carboxyl terminus in the ER lumen.
Approximately 72% and 14% of carboxylase’s sequence resides in the ER lumen and
cytoplasm, respectively. Matrix-assisted laser desorption/ionization time-of-flight mass
spectrometry results showed that there is a disulfide bond between cysteine residues 99 and
450 which is important for carboxylase folding and maturation (13). However, there is some
disagreement on whether this disulfide bond exists in active carboxylase (14).
Recently, Schmidt-Krey et al. produced planar-tubular two-dimensional crystals of
carboxylase (15). Projection map calculations reveal that the carboxylase exists as a monomer,
which agrees with sedimentation equilibrium data (16). However, the present crystal data do
not yet provide information about TMD packing or other details of the three-dimensional
structure of the carboxylase (15).
Given the limited amount of structural information about the carboxylase, it is difficult to
incorporate the information we have about residues important for function into a coherent
model of how this multisubstrate enzyme simultaneously catalyzes the carboxylation and
epoxidation reactions. When limited structural information about a protein is available,
functional splitting and reassembly of multispanning membrane proteins can be employed to
study their structure and function (17–22). It is a useful approach to study the function of protein
domains, the role of individual transmembrane helices, and the helical packing within the
membrane. Transmembrane helix interactions are important for the formation and maintenance
of three-dimensional structure in multispanning membrane proteins. Recently, several motifs
have been identified as involved in the helix–helix associations within membranes (23–25).
Changing essential residues in these motifs significantly affects the helix–helix interactions.
In order to clarify issues surrounding the disulfide bond formation and transmembrane domain
interactions and their role in structure formation, we have split human carboxylase in the last
cytoplasmic loop between TMD4 and TMD5, and coexpressed these two peptides in insect
cells. Our results show that these two peptides assemble as a fully active two-chain carboxylase
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molecule joined by a disulfide bond. Results from mutant two-chain carboxylases indicate that
TMD5 is the last and only TMD in the C-terminal peptide. In addition, it appears that TMD2
and TMD5 and at least one other domain associate via amino acid motifs expected to support
TMD interactions. Our results suggest that this two-chain carboxylase can serve as a useful
model for carboxylase structure–function studies.
MATERIALS AND METHODS
Materials
All chemicals were of reagent grade. NEM, phenylmethanesulfonyl fluoride, CHAPS, and anti-
FLAG M2 monoclonal antibody were obtained from Sigma (St. Louis, MO). Pentapeptide
FLEEL and protease inhibitor H-D-Phe-Pro-Arg chloromethyl ketone were from Bachem
(King of Prussia, PA). Aprotinin and pepstatin A were purchased from Roche Molecular
Biochemicals (Indianapolis, IN). 1,2-Dioleoyl-sn-glycero-3-phosphocholine was from Avanti
Polar Lipids (Alabaster, AL). Vitamin K1(20) (10 mg/mL) was from Abbott Laboratories
(Chicago, IL). Vitamin K1(25) was from GLsynthesis Inc. (Worcester, MA). NaH14CO3
(specific activity, 54 mCi/mmol) was from ICN Pharmaceuticals, Inc. (Costa Mesa, CA). The
peptide proFIX and the fluorescein-labeled consensus propeptide were chemically synthesized
and purified by Chiron Mimotopes (Clayton, Victoria, Australia). Restriction enzymes and
PNGase F were from New England Biolabs (Beverly, MA). The Bac-to-Bac baculovirus
expression system, Bis-Tris NuPAGE gels, protein standards, and oligonucleotides were from
Invitrogen Life Technologies (Carlsbad, CA). Pfu Turbo DNA polymerase was from
Stratagene (La Jolla, CA). Immobilon-P polyvinylidene difluoride membrane was from
Millipore Co. (Bedford, MA). ECL Western blotting detection reagents were from Amersham
Biosciences (Piscataway, NJ). Anti-HPC4 monoclonal antibody and anti-HPC4 antibody-
coupled Sepharose resin were from Dr. Charles T. Esmon (Cardiovascular Biology Research
Program, Oklahoma Medical Research Foundation, Oklahoma City, OK).
Construction of the Two-Chain Carboxylase and Site-Directed Mutagenesis
Wild-type human carboxylase cDNA with a FLAG epitope (DYKDDDDK) at the amino
terminus and a HPC4 epitope (EDQVDPRLIDGK) at the carboxyl terminus (26) was
engineered into the pFastBac1 baculovirus expression vector with BamHI and EcoRI sites. The
resulting plasmid was used as template for PCR amplifications. One-chain carboxylase is split
at amino acid residue 345 to form the two-chain carboxylase. According to the “positive inside
rule” (27,28), more positively charged residues in the cytoplasmic loop of the C-terminal
peptide will favor its correct membrane orientation. Therefore, instead of using the native
tryptic cleavage site (residue 349), we moved the split site four residues toward the N-terminus.
The N-terminal peptide (residues 1–345) was amplified by PCR using a sense oligonucleotide
comprising a BamHI site, a start codon, and part of the FLAG tag-coding sequence as the 5′
primer and an oligonucleotide containing part of the antisense coding sequence of carboxylase
ending at residues 345, a stop codon, and an EcoRI site as the 3′ primer.
The C-terminal peptide (residues 346–758) was amplified by PCR using a sense
oligonucleotide comprising a BamHI site, a start codon, and part of the carboxylase coding
sequence starting from residue 346 as the 5′ primer and an oligonucleotide containing part of
the antisense sequence of HPC4 coding sequence, a stop codon, and an EcoRI site as the 3′
primer. For individual expression of the two peptides, the PCR-amplified coding sequence of
the N-terminal peptide of carboxylase with a FLAG tag at its amino terminus or the coding
sequence for the C-terminal peptide of carboxylase with a HPC4 tag at its carboxyl terminus
was cloned into the pFastBac1 vector by BamHI/EcoRI in the multiple cloning site downstream
of the polyhedrin promoter.
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For coexpression of both peptides in insect cells, the C-terminal peptide of carboxylase was
amplified by PCR using a 5′ primer flanked with a NcoI site and 3′ primer flanked with a
KpnI site. The PCR product was first cloned into the coexpression vector pFastBacDual by
NcoI/KpnI sites in one of the multiple cloning sites downstream of the p10 promoter. The above
PCR-amplified fragment encoding the N-terminal peptide was then cloned into the pFast-
BacDual vector containing the C-terminal peptide coding sequence by BamHI/EcoRI sites in
another set of multiple cloning sites downstream of the polyhedrin promoter.
Site-directed mutagenesis of residues in the carboxylase for investigating TMD interactions or
disulfide formation was performed by overlap PCR. The nucleotide sequences of all the
constructs were verified by the DNA sequencing facility at the University of North Carolina
at Chapel Hill.
Expression of Wild-Type and Mutant Carboxylases in Insect Cells
Baculovirus expression vectors that contain the one-chain carboxylase, two-chain carboxylase,
or their mutants were transformed into Escherichia coli strain DH10Bac, the recombinant
bacmids were screened by blue/white selection, and the positive bacmids were extracted
according to the manufacturer’s instructions (Invitrogen). Recombinant baculovirus was
obtained by Cellfectin-induced infection of Sf9 cells and screened by carboxylase activity assay
or Western blot analysis of the cell lysate. Expression of carboxylase was performed by
infection of 2 × 106 Sf9 cells/mL with the recombinant virus at a multiplicity of infection of
1. Cells were collected 48 h after infection by centrifugation for microsome preparation or
stored at −80 °C until use.
Purification of Recombinant Carboxylases Using the C-Terminal Peptide Antibody Resin
Isolation of microsomes from insect cells was performed as described (29) with minor
modifications. Cells harvested from 1 L of a culture were washed twice with 100 mL of ice-
cold buffer A [25 mM Tris-HCl (pH 7.4), 150 mM NaCl, and 15% glycerol]. The washed cell
pellet was resuspended in 120 mL of ice-cold buffer A containing a protease inhibitor mixture
(0.5 μg/mL leupeptin, 1 μg/mL pepstatin, 2 μg/mL aprotinin, and 0.1 mg/mL
phenylmethanesulfonyl fluoride). Cells were broken on ice by sonication (80 pulses, 1.5 s each,
18.5 s interval between each pulse, using a Heat Systems XL2020 sonicator at a power output
of 6). The homogenate was centrifuged at 4300gav at 4 °C for 15 min. The supernatant was
recovered and centrifuged at 150000gav for 45 min at 4 °C. In order to avoid random disulfide
bond formation during the purification and sonication, in samples for gel analyses we included
20 mM NEM. In these experiments we used 25 mM MOPS (pH 6.8) in buffer A instead of 25
mM Tris-HCl (pH 7.4), since NEM reacts more specifically with cysteines at the lower pH.
Excess unreacted NEM was removed by washing the microsome pellet twice with 60 mL of
ice-cold buffer A. Solubilization of the microsomal pellet and the subsequent purification of
carboxylase using the C-terminal peptide antibody affinity resin were performed as described
(26).
Carboxylation and Epoxidation Activity Assays
Carboxylation activity was determined by the incorporation of 14CO2 into the pentapeptide
substrate FLEEL in the presence of propeptide as described (26). The concentration of active
carboxylase was determined from the fraction of protein binding to the fluorescein-labeled
consensus propeptide by fluorescence anisotropy as described previously (16).
Vitamin K epoxidation activity of carboxylase was determined by quantitation of the vitamin
K epoxide formed during carboxylation of FLEEL as described (30).
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SDS–PAGE and Western Blot Analyses
SDS–PAGE analysis was performed by the NuPAGE system (Invitrogen) under reduced or
nonreduced conditions. Samples of cell lysate, microsomes, or purified enzyme were incubated
with 1× SDS sample buffer [10% glycerol, 100 mM Tris-HCl (pH 8.5), 2% SDS, 1 mM EDTA,
0.1% bromophenol blue] in the presence or absence of 50 mM DTT at room temperature for
10 min unless otherwise stated. Samples were subjected to 10% NuPAGE for electrophoresis
using 1× MES (50 mM MES–Tris-HCl, pH 7.2, 0.1% SDS, 1 mM EDTA) or 1× MOPS (50
mM MOPS–Tris-HCl, pH 7.7, 0.1% SDS, 1 mM EDTA) running buffer. After electrophoresis,
the protein bands were visualized by silver staining or transferred to a polyvinylidene difluoride
membrane for Western blot analysis. The protein bands on the membrane were probed with
mouse C-terminal peptide antibody or the N-terminal peptide antibody, M2, followed by HRP-
conjugated secondary antibody. Protein bands were detected using the ECL Western blotting
detection reagents.
Homology Modeling of TMD2 and TMD5 Interactions
We constructed a model of the interactions between the transmembrane domains 2 and 5 based
on the X-ray crystal structure (PDB entry 1JGJ) of the membrane-embedded protein, sensory
rhodopsin II (SRII). SRII contains seven transmembrane helices. We used the helical segment,
residues 1–20 (H1) of SRII (MVGLTTLFWLGAIGMLVGTL), to model TMD2
(MYLVYTIMFLGALGMMLGLC). TMD2 has about 75% homology (40% identity) to H1.
The two helices neighboring and interacting with H1 in the SRII crystal structure, and, thus,
candidates for modeling TMD5, are the C-terminal helix 7 (H7) and helix 2 (H2). H7 is
antiparallel to our proposed TMD5 orientation; therefore, we used H2 to represent TMD5, even
though it has somewhat lower sequence identity (only 25%) with TMD5 than does helix 7. In
the X-ray crystal, the three C-terminal residues of H2 are in a turn, but in our model
construction, we made them part of the helix. Appropriate amino acid substitutions were made
to convert the SRII sequences to those corresponding to TMD2 and TMD5 using the software
package Sybyl7.3 (Tripos, Inc.). The initial model is energy minimized using the sander module
of AMBER 9.0 (31). The interaction potential was taken from the standard AMBER force field
(parm99.dat) (32) with the modifications to the backbone dihedral angles introduced by Hornak
et al. (33). The energy minimization was carried out in a dielectric medium with the dielectric
constant 4.0.
RESULTS AND DISCUSSION
Our initial goal in this study was to evaluate a two-chain carboxylase as a tool for studying
structure–function relationships in the enzyme and, in particular, to investigate the role of
certain residues in formation of the single disulfide bond in the carboxylase. Wu et al. showed
that, under controlled conditions, trypsin cleaved bovine liver carboxylase at residues 349 and
351, resulting in a two-chain molecule (7). The two chains are apparently joined by at least
one disulfide bond. This molecule had activity similar to that of the one-chain carboxylase.
Results from this study suggested to us that the two-chain carboxylase might be a good model
for studying disulfide formation and other structural features of the carboxylase.
Functional Assembly of the Two-Chain Carboxylase Expressed in Insect Cells
We expressed the N-terminal carboxylase peptide (residues 1–345), the C-terminal peptide
(345–758), and both of the two peptides together in insect cells. Western blot analyses of cell
lysates confirmed the expression of both peptides (data not shown), but neither of the two
peptides expressed alone had detectable carboxylase activity. On the other hand, when
compared to the one-chain carboxylase, the purified two-chain carboxylase had 92% and 142%,
respectively, of the carboxylase and epoxidase activity. The concentrations of proFIX required
for half-maximal stimulation of FLEEL carboxylation by the one-chain and two-chain
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carboxylases were 39.1 and 75.7 nM, respectively. This result indicates that the two-chain
carboxylase and the one-chain carboxylase have similar affinity for the vitamin K-dependent
substrate propeptide. Taken together, these results indicate that the two-chain carboxylase is
functionally assembled in vivo.
The Two-Chain Carboxylase Is Joined by a Disulfide Bond
Previously, we presented evidence that there is a disulfide bond in carboxylase between
cysteine residues 99 and 450 (7,13). However, there is some disagreement about whether the
disulfide exists (34).
Our earliest work on disulfides was with purified bovine carboxylase. When the purified
enzyme is cleaved with trypsin into two chains, it has full activity and migrates on SDS gel
analyses as a single band until the protein is reduced; then it migrates as two bands. This result
first suggested to us the existence of a disulfide bond. In our later work using recombinant
proteins, we confirmed that a disulfide bond exists in the one-chain carboxylase. In that study
using mass spectrometric analyses, we identified the residues involved in the disulfide as C99
and C450 (13). Also in this study we changed the only two cysteines, other than C450 in the
carboxy-terminal peptide, to alanine (C598/700A) and then trypsin-cleaved this carboxylase
(13). This cleaved mutant was fully active and joined by a disulfide bond, based on gel analyses.
This result confirms that C450 participates in the disulfide bond (13).
In the present study, to investigate the possibility that formation of the disulfide is an artifact
of our purification methods, we used our recombinant two-chain carboxylase. As mentioned
above, this molecule is fully active (carboxylase and epoxidase) when purified and binds factor
IXs propeptide with affinity similar to that of the wild-type carboxylase. To analyze for
disulfide formation, we purified the enzyme in the presence of NEM to minimize the chances
of spurious disulfide bond formation. Since the two-chain carboxylase migrates as one band
unless it is treated with DTT (Figure 1, lanes 2, 3, 6, and 7), the two peptides must be joined
by at least one disulfide bond.
We also analyzed this two-chain carboxylase in microsomes, to obviate any effect purification
might have on disulfide formation. In this study we again included NEM in the microsome
preparation to prevent disulfide formation. Western blot analyses (Figure 4B,C) of these
samples indicate that, in the major form of this enzyme, the two chains are joined by a disulfide
bond. As expected, on the basis of our previous results and those of Pudota et al. (34), a small
amount of the two-chain carboxylase migrates as if it were not cross-linked.
These latter results indicated to us that the two-chain molecule is functionally intact and,
therefore, that it must have a structure similar to that of the one-chain molecule and will be a
useful model for studying carboxylase.
Proline 378 Is Important for Disulfide Formation
Proline residues at the membrane interface of transmembrane helices often play important roles
in orienting essential residues in directions appropriate for protein function through the
formation of a helix kink and/or swivel angles (35,36). In carboxylase, there is a proline near
the lumenal helix surface of both TMD1 (P80) and TMD5 (P378). We thought these two
prolines might contribute to formation of the disulfide bond between cysteines 99 and 450. To
test this hypothesis, we mutated P80 and P378 to leucine individually in the two-chain
carboxylase.
Mutation of residue P80, which has activity similar to that of wild-type carboxylase (results
not shown), has a minor effect on disulfide formation. On the other hand, P378L significantly
decreased the disulfide formation in carboxylase (Figure 2A). These results were derived from
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scanning the blot (Figure 2C) of the affinity-purified two-chain carboxylase and its P80L and
P378L mutants under nonreducing conditions.
The P80L two-chain carboxylase (lanes 2 and 6) behaves similarly to the wild-type two-chain
carboxylase (lanes 1 and 5) under both reducing and nonreducing conditions. This indicates
that the majority of the two peptides of the P80L mutant two-chain carboxylase are linked by
a disulfide bond. On the other hand, P378L has dramatically less disulfide-linked two-chain
carboxylase (lane 3). It also has other protein bands which might represent degradation products
caused by incorrect folding of the carboxylase. This interpretation is consistent with our
previous observations (13) in which mutation of C99 and/or C450, the two cysteines we
identified as forming the disulfide bond, caused degradation of the purified carboxylase. These
results suggest that proline 378, but not proline 80, is important for disulfide bond formation
in carboxylase. This is consistent with the fact that P378, but not P80, is conserved across
species as diverse as Drosophila and humans.
Interestingly, in the P378L sample (Figure 2B, lane 3), there is a protein band that migrates
the same as the N-terminal peptide. Since, for the most part, there is no disulfide bond holding
the two chains together, and we purify the protein using the C-terminal tag, if the disulfide
bond were the only interaction between the two chains, one would expect the N-terminal
peptide to be lost during purification.
To determine if this band represented the N-terminal peptide, we probed the gel with the N-
terminal peptide antibody (anti-FLAG) for Western blot analysis. The band at 30000 apparent
molecular weight is recognized by the N-terminal peptide antibody, indicating that it is the N-
terminal peptide of the two-chain carboxylase (Figure 2C, lanes 3 and 7). Therefore, the N-
terminal peptide copurified with the noncovalently linked C-terminal peptide, suggesting that,
in addition to the disulfide, there must be other noncovalent linkages between the two peptides
in the two-chain carboxylase. A likely source would be interaction between the TMDs.
We observed SDS-resistant oligomerization of carboxylase or its peptides (Figures 2–5).
Oligomerization was especially prevalent in the TMD-rich N-terminal peptide. We previously
observed high molecular weight aggregates when we heated samples to ensure protein
denaturation in SDS/DTT before gel analyses. For that reason we now routinely treat our
samples with SDS and DTT at room temperature for 15 min. These higher molecular weight
forms appear to be more predominant in carboxylase without the disulfide bond. For example,
among the nonreduced samples (Figure 2C) only that of the P378L (lane 3) two-chain
carboxylase, in which most of the disulfide bond is disrupted, shows significant oligomers. In
addition, the wild-type two-chain carboxylase only exhibits significant oligomer formation
under reducing conditions (Figure 2C, lane 5). In all cases, however, the predominant form of
the N-terminal peptide was the monomer. To investigate whether these bands, as we expected,
were the result of sample preparation, we tested the effect of temperature, DTT, and SDS on
the extent of oligomerization. The oligomer bands increased with incubation at 80 °C,
especially with DTT but no SDS (results not shown). This indicates that the reduced form is
more susceptible to association. The oligomers may be due to hydrophobic interactions
between the TMDs as found in other membrane proteins (37–40). As we reported, the
functional one-chain carboxylase is a monomer (15, 16). Therefore, we conclude that
oligomerization of the N-terminal peptide is not likely to have any biological significance and,
thus, should not affect the interpretation of our results.
TMD5 Is the Only TMD in the C-Terminal Peptide of the Two-Chain Carboxylase
According to our membrane topology of carboxylase, there are five TMDs in carboxylase, and
TMD5 is the only TMD in the C-terminal peptide of the two-chain carboxylase (12). TMD5
must therefore direct the large hydrophilic carboxyl terminus of carboxylase to the lumen of
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the ER. We previously showed that all of the carboxylase glycosylation sites are in the C-
terminal peptide and, thus, must be in the lumen, which adds further support for our model
(30).
If our topology model is right, and TMD5 is the only TMD in the C-terminal peptide, then two
things must be true: first, if TMD5 is disrupted in the one-chain carboxylase, the carboxyl
terminus will be in the cytoplasm, and it will not be glycosylated, and second, TMD5 must be
involved in any interaction that involves the C-terminal peptide and another TMD. If the first
criterion is true, then this form of carboxylase will migrate faster in SDS–PAGE analysis than
does glycosylated carboxylase (30). If the second is true, disruption of TMD5 in the two-chain
carboxylase will result in a non-membrane-associated C-terminal peptide and the peptide will
not appear in Western blots of microsomes. If, on the other hand, there is another TMD in the
C-terminal peptide, or a membrane-associated domain, then glycosylation may be normal and
the peptide should still be associated with the microsomal membrane.
To test this hypothesis, we simultaneously mutated residues L368 and L372 in TMD5 to proline
(L368/372P) to disrupt the transmembrane helix. We made both the one-chain and two-chain
forms of the mutant carboxylases. We prepared microsomes from insect cells expressing wild-
type and these mutant carboxylases and analyzed them by SDS–PAGE under nonreducing
conditions. Protein bands were visualized on the Western blot using the C-terminal peptide
antibody (Figure 3A) and the N-terminal peptide antibody (Figure 3B). As expected if our
model is correct, the one-chain L368P/L372P carboxylase (Figure 3A, lane 2) migrates faster
than the wild-type carboxylase (lane 1). It migrates the same as the deglycosylated wild-type
carboxylase (lane 4) when all carbohydrates were removed from wild-type carboxylase by
endoglycosidase, PNGase F. In addition, migration of the L368P/L372P one-chain carboxylase
is not affected by PNGase F treatment (lane 5). These results suggest that when TMD5 was
disrupted in the one-chain carboxylase, the large hydrophilic carboxyl terminus of carboxylase
is not translocated into the ER lumen for glycosylation.
The result with the one-chain mutant suggests that disruption of TMD5 in the two-chain mutant
will cause the C-terminal peptide to dissociate from microsomal membranes unless there is a
membrane-associated domain in that peptide. In microsomes prepared from cells expressing
the two-chain L368P/L372P carboxylase, we did not detect the C-terminal peptide. This result
indicates that it is no longer associated with the membrane (Figure 3A, lane 3). In sum, this
indicates that TMD5 is the last TMD in carboxylase, and the only one in the C-terminal peptide,
and there is no membrane-associated domain in the C-terminal peptide.
To ensure that the result described above for the two-chain mutant was not because the C-
terminal peptide was not expressed, we analyzed whole cell lysate of cells putatively expressing
two-chain L368P/L372P. A Western blot analysis of the lysate from these cells using the C-
terminal peptide antibody revealed a peptide migrating at approximately 16 kDa (data not
shown). This suggests that the C-terminal peptide is expressed, but due to improper folding, it
is more susceptible to proteolysis and is degraded.
Figure 3B shows the same blot as in Figure 3A but probed by the N-terminal peptide antibody.
As expected, the one-chain form is detected as in Figure 3A. The two-chain L368P/L372P
carboxylase (lane 3) N-terminal peptide is expressed properly even when its C-terminal partner
is not associated with the membrane. These results suggest that TMD5 is the only TMD in the
C-terminal peptide of the two-chain carboxylase.
An Interaction between TMD2 and TMD5 Is Important for Carboxylase Assembly
The obvious question at this point in our investigation was what is the other TMD interacting
with TMD5? Recently, three motifs that are important for TMD helix–helix interactions have
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been identified: the GxxxG motif and its like, polar and hydrogen-bonding motifs, and proline
motifs (for review, see ref 23). Glycine motifs have been shown to support a hydrogen bond
network that stabilizes domain–domain interactions (41). Among the five TMDs in
carboxylase, there is a GxxxG (residues 128 and 132) motif in TMD2. In addition, in human
carboxylase TMD5, there is a GxxxT (residues 363 and 367) sequence that also has been
identified as supporting TMD interactions. In both cases, since they are separated by three
amino acids, the residues of interest will be on the same face of the TMD helix. The presence
of the GxxxG sequence in TMD2 suggested to us that TMD2 was a likely candidate for TMD–
TMD interactions, perhaps with TMD5. The GxxxT sequence in TMD5 may be involved in
the interactions in which TMD5 participates. In order to investigate this potential TMD
interaction, we made five mutant carboxylases. We changed the glycines in the TMD2 motif
(128 and 132), as well as the nearby G125, to leucine. In addition we created two carboxylases
with either G363L/T367L or E373L/Q374L mutations, all in TMD5. The E373L/Q374L was
to test whether these polar and/or charged residues are important for a TMD interaction. We
chose leucine for substitution since it tends to support helix formation and would therefore be
less likely to disrupt the TMD structure. Our logic was that if these residues do support TMD
association, then they may be important for ensuring the proximity necessary for disulfide
formation, and thus mutation may result in less disulfide formation between the carboxylase’s
two chains.
All three glycine mutations in the two-chain carboxylase caused decreased disulfide bond
formation, and in addition, both peptides of G125L were degraded (Figure 4). This suggests
that the glycines in TMD2 are important for carboxylase structure but does not tell us directly
whether TMD2 interacts with another TMD, especially TMD5.
To further explore this question, we purified the two-chain carboxylases that were the least
degraded, G128L and G132L. Our rationale for this experiment was that if the N-terminal and
C-terminal peptides of either G128L or G132L two-chain carboxylase associate through
interactions other than the disulfide bond or a TMD2-TMD5 interaction, then we would expect
both peptides of the two-chain molecules to be purified using our methodology which, as
described, employs an antibody tag on the C-terminus. The N-terminal peptide should be
present in both reduced and unreduced samples. If, on the other hand, the disulfide bond and
a TMD interaction between TMDs 2 and 5 are the only significant association between the N-
and C-terminal peptides, then the N-terminal peptide should only be present in disulfide-
bonded purified G128L and G132L two-chain mutants.
In the purified G128L and G132L two-chain carboxylases the N-terminal peptide is visible
only in the reduced sample (Figure 5B, lanes 4 and 5). This result is consistent with our
hypothesis that the TMD interaction is between TMD2 and, since it is the only TMD in the C-
terminal peptide, TMD5. Additionally, this indicates that the only interactions between these
peptides are the TMD interaction and the disulfide bond.
When we mutated TMD residues in the C-terminal peptide to test for polar/charge residues
(G363L/T367L and E373L/Q374L) that might be involved in the TMD interaction, the proteins
were highly degraded (results not shown). This result suggests the residues are important for
structure formation but does not offer further information about the TMD interaction and the
participating residues in TMD5. However, our model described below does suggest that these
results are consistent with participation in a TMD interaction.
Analysis of the Homology Model in the Context of Our Experimental Results
In order to offer possible structural explanations for our experimental results, we constructed
a model (Figure 6) of the TMD2 and TMD5 interaction. The residues that we changed in the
carboxylase are highlighted using a space-filling representation. Residues that we mutated,
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G363, T367, E373, and Q374, along with F366, Y370, and L377 comprise the interacting
surface of TMD5 (Figure 6A). G363L/T367L and E373L/Q374L two-chain carboxylases were
heavily degraded, which, while not offering direct evidence as to structural interactions,
indicates that these residues are important and is consistent with the model.
In the model structure, G125, G128, and G132 in TMD2 are stacked along the helix, but only
G125 appears to be part of the TMD5–TMD2 interface. In addition, all four methionines in
TMD2 and Y119, F123, and A126 interact with TMD5. Since G125L is on the TMD2–TMD5
interface, our results showing degradation of G125L are consistent with the model. Apparently
changing glycine to a bulkier leucine residue leads to a complete disruption of this interacting
surface since the side chain would be competing for the space occupied in the wild-type enzyme
by Y370 and F366 of TMD5. These latter residues have a π electron interaction.
If G125 forms part of the TMD2–TMD5 interface, as seems likely, then G128 and, therefore,
G132 cannot. This is because G128 and G125 are separated by only two residues. Three
intervening residues are necessary to complete the helix turn and position the residues on the
same side.
The model suggests it is more likely that both G128 and G132 are on the helix face not
associated with TMD5. This means that the two residues, which are on a face of TMD2 with
four leucine residues (L117, L124, L127, and L131), might be interacting with another TM
domain in addition to TMD5 (Figure 6B). According to our model, if G128 and G132 are not
interacting with another TMD (besides TMD5), the helix should readily accommodate the
leucine mutations because the substituted side chains would be oriented away from the TMD5
interface. However, our results indicate that G128 and G132 mutations do cause structural
disruption, evidenced by decreased disulfide formation. If such an interaction surface exists,
and the glycine motif supports the interaction, then, as we observe, substitution of the bulky
leucine residues would disrupt this network.
If TMD2 forms a complex with TMD5 and one or more other TMDs, it may be that mutations
disrupting either of the TMD2’s interactions might disrupt the complex as a whole. In other
words, TMD2 may be acting as an anchor for the TMD complex. This would be consistent
with our results that show the disulfide bond is disrupted in both G128L and G132L and that
direct interaction between TMD2 and TMD5 is disrupted in those mutant carboxylases. A
likely candidate for the other TMD involved would be TMD4, since it has five serine residues
which are common in sequences identified as supporting TMD associations (42). However,
since we only modeled TMDs 2 and 5, our homology construct does not constitute the entire
neighborhood of G128 and G132; therefore, it is somewhat difficult to predict the outcome of
G128L and/or G132L mutations with the current model. Our results do, however, indicate that
further study of TMD interactions in the carboxylase will provide new structural information
and perhaps insight into structure–function relationships in this enzyme.
It is too early to describe a detailed model for the carboxylase structure. However, we are
tempted to speculate about how our results and previously published information fit together.
From what we know about carboxylase, purified carboxylase is a monomer; the propeptide
binding site, glutamate binding site, and active site must be in close spatial proximity. In almost
all vitamin K-dependent proteins the propeptide and Gla domain are adjacent in sequence. The
propeptide anchors the substrate for multiple carboxylations without the propeptide
dissociating, thus allowing the substrate to be repositioned, with respect to the active/binding
site. Whether the carboxylase or the Gla domain moves is not known, but the propeptide
remains bound. In addition, the glutamate site must be near the putative K218 active site residue
for two reasons. First, the lysine presumably activates vitamin K (11), leading to removal of
the γ proton of glutamate. Second, the positive charge of either K218 or K217 is likely to bind
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to the negatively charged glutamate. According to quantum chemical calculations, this second
step is apparently necessary to facilitate the γ proton removal (43).
These notions fit with the idea that TMD interactions may be necessary for correct carboxylase
conformation. The combination of the 99–450 disulfide bond and the proposed TMD2 and
TMD5 interaction would bring the glutamate binding region around L394 (10) into proximity
of the N-terminal sequence. The L394 sequence is near the exit of TMD5 from the membrane
so its position is dependent on the location of TMD5. This is consistent with results implicating
certain lumenal carboxylase N-terminal sequences in glutamate and propeptide binding, as
well as K218’s apparent role in catalysis (6,9,11).
If the serines in TMD4 are interacting with TMD2 through the glycine motif or otherwise, then
it would tend to limit the location of the long lumenal sequence containing K218 and make it
more likely to be in proximity of the important sequences in the C-terminal region. Moreover,
the disulfide bond would also tend to bring the C-terminal sequence involved in propeptide
binding (438 to ~515) closer to the above regions.
In conclusion, we have provided further evidence supporting the existence of a disulfide bond
in carboxylase. We have shown that the fifth transmembrane domain of carboxylase is the last
and only such domain in the C-terminal peptide of our two-chain carboxylase. In addition, our
results reveal the importance of proline 378 in the structure necessary for formation of the
enzyme’s disulfide bond. Lastly, we found that it is likely the second and fifth transmembrane
domains of carboxylase interact through previously described motifs commonly supporting
these types of interactions and describe a structural model consistent with our results.
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SDS gel electrophoretic analyses of purified recombinant human one-chain and two-chain
carboxylases. Affinity-purified one-chain carboxylase (lanes 1 and 5), two-chain carboxylase
(lanes 2 and 6), and NEM-labeled two-chain carboxylase (lanes 3 and 7) were fractionated by
SDS–PAGE under nonreduced (NR) and reduced (R) conditions and visualized by silver stain.
The N-terminal and C-terminal peptides are indicated by arrows.
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Determination of disulfide bond formation in purified two-chain carboxylase and P80L and
P378L two-chain carboxylases by SDS gel electrophoretic and Western blot analyses. Affinity-
purified NEM-labeled two-chain carboxylase (in both panels B and C, lanes 1 and 5) and P80L
two-chain (panels B and C, lanes 2 and 6) and P378L two-chain carboxylases (panels B and
C, lanes 3 and 7) were analyzed by SDS–PAGE under reduced (R) and nonreduced (NR)
conditions. Protein was visualized by silver stain (B) or Western blot using the antibody to the
N-terminal peptide as the primary antibody (C). The percentage of disulfide bond formed in
the mutants relative to that in carboxylase shown in panel A was determined by scanning the
blot in panel C. The N-terminal and C-terminal peptides are indicated by arrows. Disulfide-
linked P378L mutant two-chain carboxylase (B) and the dimer of the N-terminal peptide (C)
are indicated by an asterisk.
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Western blot analyses of one-chain carboxylase and one- and two-chain L368/372P
carboxylase and PNGase F-treated forms of these carboxylases. Microsomes from cells
expressing either wild-type carboxylase or the carboxylase L368/372P were analyzed by SDS–
PAGE under nonreduced conditions and transferred to a polyvinylidene difluoride membrane.
Protein bands were visualized using the antibody to the C-terminal carboxylase peptide (A) or
the antibody to the N-terminal peptide (B) employing ECL reagents. One-chain wild-type
carboxylase (lane 1 in panels A and B), one-chain L368/372P (lane 2 in both panels), two-
chain L368/372P (lane 3 in both panels), PNGase F-treated wild-type carboxylase (lane 4 in
both panels), and PNGase F-treated one-chain L368/372P (lane 5 in both panels). One-chain
carboxylase (A) and the N-terminal peptide (B) are indicated by arrows. The dimer of the N-
terminal peptide (B) is indicated by an asterisk.
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Western blot analyses of carboxylase and the mutant carboxylases G125L, G128L, and G132L.
Freshly prepared microsomes from cells expressing two-chain carboxylase (lanes 1 and 6,
panels B and C), G125L two-chain carboxylase (lanes 2 and 7, panels B and C), G128L two-
chain carboxylase (lanes 3 and 8, panels B and C), and G132L two-chain carboxylase (lanes
4 and 9, panels B and C) were labeled by NEM and analyzed by SDS–PAGE under reduced
(R) and nonreduced conditions (NR). Proteins were visualized by Western blot using the
antibody to the C-terminal peptide (B) and the antibody to the N-terminal peptide (C) as the
primary antibodies. The percentage of disulfide bond formed in the mutant carboxylases (A)
relative to wild-type carboxylase was determined by scanning the gel in panel B. The N-
terminal and C-terminal peptides are indicated by arrows. Disulfide-linked G128L mutant two-
chain carboxylase (B) is indicated by an asterisk.
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Western blot analyses of purified G128L and G132L two-chain carboxylases. Affinity-purified
NEM-labeled G128L (lanes 1 and 4, both panels) and G132L two-chain carboxylases (lanes
2 and 5, both panels) were analyzed by SDS–PAGE under reduced (R) and nonreduced (NR)
conditions. Protein bands were detected by Western blot using the C-terminal peptide antibody
(A) or the N-terminal peptide antibody (B). The arrow in panel A indicates the C-terminal
peptide, and the arrow in panel B indicates the N-terminal peptide.
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Homology model of TMD2 and TMD5. Two views of the homology model showing residues
of interest in transmembrane domains 2 and 5 with space-filling representations.
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